
Over 56k GES teachers paid promotion arrears ahead of deadline
2 mins read
12th November 2023 1:51:17 PM
2 mins readBy: Chris Kodo

The Food and Drugs Authority (FDA), in collaboration with medicine regulatory agencies and non-governmental organizations, has launched the “#MedSafetyWeek” campaign, scheduled from November 6th to 12th, 2023.
According to a statement received by the Ghana News Agency, the campaign focuses on medicine safety monitoring, aiming to gather information about both known and new side effects.
Under the theme “Who can report,” the campaign aims to underscore the importance of reporting side effects of medicines. It emphasizes the vital role played by patients, caregivers, doctors, nurses, and pharmacists in reporting these side effects to ensure medicine safety.
The continuous collection and monitoring of these reports will aid the FDA in identifying potential risks associated with medicines. This information will enable the FDA to take necessary regulatory actions to enhance medicine safety.
“The FDA emphasises the importance of reporting side effects by using reporting forms available in healthcare facilities and community pharmacies designated as patient safety centres or by using the Med Safety App”, the statement said.
The Med Safety Application stands as a user-friendly electronic reporting tool, offering convenient accessibility.
This application is readily accessible on both the App Store and Google Play Store.
Individuals are also urged to submit reports to any of the FDA's regional offices across the country. The reports are meticulously assessed to take the necessary measures in safeguarding public health and safety.
Over time, the FDA has effectively processed numerous reports, significantly aided by patients, caregivers, and healthcare professionals.
It strongly encourages all citizens to actively contribute to safer medications by identifying and reporting potential side effects.
2 mins read
2 mins read
2 mins read
2 mins read
6 mins read
3 mins read
2 mins read
3 mins read
3 mins read